ReviewApplied biochemistry and biotechnology2021
A Review on Green Synthesis, Characterization and Anticancer Application of Metallic Nanoparticles.
Review in Applied biochemistry and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 23 citations in OpenAlex.
- Investigating antibacterial activity of biosynthesized silver oxide nanoparticles using Phragmanthera Macrosolen L. leaf extract.Scientific reports · 2024Article
- The quest for nanoparticle-powered vaccines in cancer immunotherapy.Journal of nanobiotechnology · 2024Review
- Green Synthesis of Silver Nanoparticles and their Potential Applications in Mitigating Cancer.Current pharmaceutical design · 2024Review
- Induction of Browning in White Adipocytes: Fucoidan Characterization and Gold Nanoparticle Synthesis fromMarine drugs · 2023Article
- Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications.Journal of nanobiotechnology · 2022Review
- Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K/Akt/mTOR signaling pathway.Journal of nanobiotechnology · 2022Article
- Preparing Copper Nanoparticles and Flexible Copper Conductive Sheets.Nanomaterials (Basel, Switzerland) · 2022Article
Corrections and comments
- Retraction · 2024-09-16Euphemisms for Plagiarism · Objections by Author(s) · Plagiarism of/in Article · Computer-Aided Content or Computer-Generated Content ·
- Retracted
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is one of the leading causes of death worldwide and also the main obstacle of accelerating anticipation. It is globally recognized as overwhelmingly challenging in terms of clinical management. Cancer is taken into account because a prime lethal disease affects different organs of the body. Even with the rapid improvements in the medical sciences, there are no proper medicines to treat specific kinds of cancer. One of the fundamental issues within the malignant growth treatment is the side effect because of conventional treatment systems. Nanotechnology might be an extremely encouraging field for the therapeutic and drug areas; thus, it assumes a crucial part in improving humankind's satisfaction. In the infield of nanotechnology, a plant-mediated fusion of metal nanoparticles has been developed as a substitute to defeat the limitations of traditional synthesis approaches similar to physical and synthetic strategies. These tunable properties of nanomaterials make them progressed apparatuses in the biomedical platform particularly for the improvement of new diagnostics and focused on therapeutics for malignancy.This review incorporates the characterization of nanoparticles with size and shape and features critical uses of biosynthesized green nanomaterials in cancer theranostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.